how glp-1 works for weight loss and loss: What you eat matters GLP-1 Genetics: How Genes Affect

The FDA boxed warning specifically contraindicates certain GLP-1 receptor agonists in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with multiple endocrine neoplasia syndrome type 2 (MEN 2)

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system

Results Scoping Review The databases and resource searches yielded 1753 records

There are more than 110 plaintiffs alleging sudden blindness or major vision changes lawsuits claim non-arteritic anterior ischemic optic neuropathy (NAION), sometimes described as an eye stroke. A 2024 JAMA Ophthalmology study found an association between semaglutide and increased NAION risk, though researchers did not establish causation